{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:06:55Z","timestamp":1789913215277,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1006\/jaut.2002.0617","type":"journal-article","created":{"date-parts":[[2002,12,10]],"date-time":"2002-12-10T15:43:20Z","timestamp":1039535000000},"page":"215-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["TNF\u03b1 Inhibition in MRL\/lpr Mice Ameliorates Pulmonary but not Renal Disease"],"prefix":"10.1006","volume":"19","author":[{"given":"Nahmah","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lashon","family":"Ussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran","family":"Murali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/jaut.2002.0617_RF1","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.162.4.2415","article-title":"Genetic dissection of SLE pathogenesis: adoptive transfer of SLE1 mediates the loss of tolerance by bone marrow derived B cells","volume":"162","author":"Sobel","year":"1999","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF2","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.4049\/jimmunol.147.8.2536","article-title":"B lymphocytes from the autoimmune-prone mouse strain MRL\/lpr manifest an intrinsic defect in tetraparental MRL\/lpr-DBA\/2 chimeras","volume":"147","author":"Nemazee","year":"1991","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.145.2.549","article-title":"Evidence for an intrinsic B cell defect in lpr\/lpr mice apparent in neonatal chimeras","volume":"145","author":"Perkins","year":"1990","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ki.1995.14","article-title":"Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms","volume":"47","author":"Yokoyama","year":"1995","journal-title":"Kidney Int"},{"key":"10.1006\/jaut.2002.0617_RF5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1006\/jaut.1996.0063","article-title":"Dysregulated transforming growth factor-beta in neonatal and adult autoimmune MRL-lpr mice","volume":"9","author":"Kreft","year":"1996","journal-title":"Journal of Autoimmunity"},{"key":"10.1006\/jaut.2002.0617_RF6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000045475","article-title":"Enahnced hyaluronan synthesis in MRL-Fas(lpr) kideny: role of cytokines","volume":"83","author":"Feusi","year":"1999","journal-title":"Nephron"},{"key":"10.1006\/jaut.2002.0617_RF7","first-page":"S79","article-title":"TNFa is expressed early in skin lesions in MRL\/lpr mice followed by an increase in IL-10","volume":"40","author":"Criscione","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1006\/jaut.2002.0617_RF8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jlb.57.2.242","article-title":"In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL-lpr\/lpr mice","volume":"57","author":"Hecht","year":"1995","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1006\/jaut.2002.0617_RF9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4049\/jimmunol.157.1.427","article-title":"TNF-alpha enhances colony stimulating factor-1-induced macrophage accumulation in autoimmune renal disease","volume":"157","author":"Moore","year":"1996","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF10","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.4049\/jimmunol.157.4.1758","article-title":"Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr\/lpr mice by a transcriptional inhibitor of TNF-a","volume":"157","author":"Edwards","year":"1996","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF11","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4049\/jimmunol.143.11.3470","article-title":"Tumor necrosis factor and IL-1 in New Zealand black\/white mice","volume":"143","author":"Brennan","year":"1989","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/096120330000900703","article-title":"Induction of anti-DNA antibodies by immunization with anti-DNA antibodies: mechanism and characterization","volume":"9","author":"Satake","year":"2000","journal-title":"Lupus"},{"key":"10.1006\/jaut.2002.0617_RF13","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.4049\/jimmunol.158.6.3009","article-title":"Kinetics of cytokine production in experimental systemic lupus erythematosus","volume":"158","author":"Segal","year":"1997","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1191\/096120301675275538","article-title":"Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline","volume":"10","author":"Segal","year":"2001","journal-title":"Lupus"},{"key":"10.1006\/jaut.2002.0617_RF15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2249.1995.tb02278.x","article-title":"Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation","volume":"101","author":"Segal","year":"1995","journal-title":"Clin. Exp. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF16","first-page":"419","article-title":"Tumor necrosis factor alpha induces glomerular damage in the rabbit","volume":"134","author":"Bertani","year":"1989","journal-title":"Am. J. Path"},{"key":"10.1006\/jaut.2002.0617_RF17","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1172\/JCI119649","article-title":"Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (\u2212\/\u2212) mice","volume":"100","author":"Carballo","year":"1997","journal-title":"J. Clin. Invest"},{"key":"10.1006\/jaut.2002.0617_RF18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.281.5379.1001","article-title":"Feedback inhibition of macrophage tumor necrosis factor-a production by tristetraprolin","volume":"281","author":"Carballo","year":"1998","journal-title":"Science"},{"key":"10.1006\/jaut.2002.0617_RF19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1074-7613(00)80411-2","article-title":"A pathologic role for TNFa in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency","volume":"4","author":"Taylor","year":"1996","journal-title":"Immunity"},{"key":"10.1006\/jaut.2002.0617_RF20","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.156.8.3043","article-title":"Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3\u2032-untranslated region in the genetic predisposition to lupus-like autoimmune disease","volume":"156","author":"Jacob","year":"1996","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis","volume":"94","author":"Cope","year":"1994","journal-title":"J. Clin. Invest"},{"key":"10.1006\/jaut.2002.0617_RF22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/1043-4666(91)90481-R","article-title":"Tumor necrosis factor alpha in murine systemic lupus erythematosus disease models: implications for genetic predisposition and immune regulation","volume":"3","author":"Jacob","year":"1991","journal-title":"Cytokine"},{"key":"10.1006\/jaut.2002.0617_RF23","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4049\/jimmunol.144.5.1753","article-title":"Effects of recombinant murine tumor necrosis factor-a on immune function","volume":"144","author":"Gordon","year":"1990","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0090-1229(89)90157-8","article-title":"Chronic therapy with r ecombinant tumor necrosis factor-a in autoimmune NZB\/NZW F1 mice","volume":"52","author":"Gordon","year":"1989","journal-title":"Clin. Immunol. Immunopathol"},{"key":"10.1006\/jaut.2002.0617_RF25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.179.1.305","article-title":"Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZ B\/W F1 mice","volume":"179","author":"Ishida","year":"1994","journal-title":"J. Exp. Med"},{"key":"10.1006\/jaut.2002.0617_RF26","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.4049\/jimmunol.159.6.2658","article-title":"Delay in the onset of system immunomodulator AS 101","volume":"159","author":"Kalechman","year":"1997","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF27","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4049\/jimmunol.167.12.6821","article-title":"In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL","volume":"167","author":"Via","year":"2001","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1191\/096120398678919949","article-title":"Renal expression of IL-6 and TNF-alpha genes in lupus nephritis","volume":"7","author":"Herrerea-Esparza","year":"1998","journal-title":"Lupus"},{"key":"10.1006\/jaut.2002.0617_RF29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000190225","article-title":"Glomerular ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis","volume":"76","author":"Yokoyama","year":"1997","journal-title":"Nephron"},{"key":"10.1006\/jaut.2002.0617_RF30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.147.1.117","article-title":"Elevated levels of endogenous IL-6 in systemic lupus erythematosus","volume":"147","author":"Linker-Israeli","year":"1991","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/096120339300200605","article-title":"Profiles of cytokines (TNF\u03b1 and IL-6) and acute phase proteins (CRP and al AG) related to disease course in patients with systemic lupus erythematosus","volume":"2","author":"Meijer","year":"1993","journal-title":"Lupus"},{"key":"10.1006\/jaut.2002.0617_RF32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/rheumatology\/35.11.1067","article-title":"Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus","volume":"35","author":"Studnicka-Benke","year":"1996","journal-title":"Brit. J. Rheum"},{"key":"10.1006\/jaut.2002.0617_RF33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/clin.1996.0181","article-title":"Thalidomide as an anti-TNF\u03b1 inhibitor: implications for clinical use","volume":"81","author":"Klausner","year":"1996","journal-title":"Clin. Immunol. Immunopathol"},{"key":"10.1006\/jaut.2002.0617_RF34","first-page":"487","article-title":"Treatment of the cutaneous lesions of systemic lupus erythematosus with thalidomide","volume":"11","author":"Atra","year":"1993","journal-title":"Clinical & Experimental Rheumatology"},{"key":"10.1006\/jaut.2002.0617_RF35","first-page":"1353","article-title":"Long-term thalidomide therapy for cutaneous lesions of systemic lupus erythematosus","volume":"9","author":"Sato","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1006\/jaut.2002.0617_RF36","first-page":"S253","article-title":"Thalidomide in the treatment of cutaneous manifestations of lupus erythematosus","volume":"39","author":"Stevens","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1006\/jaut.2002.0617_RF37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1046\/j.1523-1747.2000.00118.x","article-title":"Association of a promoter polymorphism of TNFa with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription","volume":"115","author":"Werth","year":"2000","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1006\/jaut.2002.0617_RF38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1155\/1994\/756247","article-title":"Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus","volume":"12","author":"Danis","year":"1995","journal-title":"Dis. Markers"},{"key":"10.1006\/jaut.2002.0617_RF39","first-page":"89","article-title":"Effects of a tumor necrosis factor promoter base 167 transition on transcriptional activity","volume":"33","author":"Wilson","year":"1994","journal-title":"Brit. J. Rheum"},{"key":"10.1006\/jaut.2002.0617_RF40","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/art.1780401215","article-title":"A promoter polymorphism of tumor necrosis alpha is associated with systemic lupus erythematosus in African Americans","volume":"40","author":"Sullivan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1006\/jaut.2002.0617_RF41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-3083.1998.00427.x","article-title":"Differential oncogene and TNFa mRNA expression in bone marrow cells from systemic lupus erythematosus patients","volume":"48","author":"Alvarado-de la Barrera","year":"1998","journal-title":"Scand. J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF42","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1073\/pnas.87.3.1233","article-title":"Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor \u03b1: relevance to genetic predisposition to systemic lupus erythematosus","volume":"87","author":"Jacob","year":"1990","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1006\/jaut.2002.0617_RF43","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials","volume":"43","author":"Charles","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1006\/jaut.2002.0617_RF44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","article-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N. Engl. J. Med"},{"key":"10.1006\/jaut.2002.0617_RF45","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1006\/jaut.2002.0617_RF46","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1074-7613(01)00201-1","article-title":"Delineating the genetic basis of systemic lupus erythematosus","volume":"15","author":"Wakeland","year":"2001","journal-title":"Immunity"},{"key":"10.1006\/jaut.2002.0617_RF47","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/nbt1197-1266","article-title":"Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor","volume":"15","author":"Takasaki","year":"1997","journal-title":"Nat. Biotechnol"},{"key":"10.1006\/jaut.2002.0617_RF48","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2249.1991.tb05737.x","article-title":"Tumour necrosis factor\/cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice","volume":"85","author":"Deguchi","year":"1991","journal-title":"Clin. Exp. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF00412976","article-title":"Evaluation of ATPase-positive Langerhans' cells in skin lesions of lupus erythematosus and experimentally induced inflammations","volume":"281","author":"Kanauchi","year":"1989","journal-title":"Archives of Dermatological Research"},{"key":"10.1006\/jaut.2002.0617_RF50","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.4049\/jimmunol.141.9.3050","article-title":"Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis","volume":"141","author":"Boswell","year":"1988","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ki.1996.290","article-title":"Cytokine gene expression in the MRL\/lpr model of lupus nephritis","volume":"50","author":"Lemay","year":"1996","journal-title":"Kidney Int"},{"key":"10.1006\/jaut.2002.0617_RF52","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.156.8.2661","article-title":"Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I","volume":"156","author":"Zhou","year":"1996","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"Ji","year":"2002","journal-title":"Immunity"},{"key":"10.1006\/jaut.2002.0617_RF54","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1354\/vp.38-3-261","article-title":"Expression of E- and P-selectin in tumor necrosis factor-induced dermatitis in dogs","volume":"38","author":"Tremblay","year":"2001","journal-title":"Veterinary Pathology"},{"key":"10.1006\/jaut.2002.0617_RF55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00024382-199809000-00006","article-title":"Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat","volume":"10","author":"Colletti","year":"1998","journal-title":"Shock"},{"key":"10.1006\/jaut.2002.0617_RF56","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.4049\/jimmunol.160.8.4074","article-title":"IFN-g limits macrophage expansion in MRL-Fas lpr autoimmune interstitial nephritis: a negative regulatory pathway","volume":"160","author":"Schwarting","year":"1998","journal-title":"J. Immunol"},{"key":"10.1006\/jaut.2002.0617_RF57","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4049\/jimmunol.161.1.494","article-title":"IFN-g receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Faslpr Mice","volume":"161","author":"Schwarting","year":"1998","journal-title":"J. Immunol"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841102906177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841102906177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T07:53:31Z","timestamp":1760255611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841102906177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S0896841102906177"],"URL":"https:\/\/doi.org\/10.1006\/jaut.2002.0617","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF\u03b1 Inhibition in MRL\/lpr Mice Ameliorates Pulmonary but not Renal Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/jaut.2002.0617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}